Due to these characteristics, CD38 could represent an effective molecule to be targeted by therapeutic antibodies in the management of AL amyloidosis, a pathologic condition characterized by high expression of this molecule at the cell surface level [19]. This evidence concerns the gene CD38 and AL amyloidosis.